FDA.reportPublic FDA data

Intuniv 4 MG 24 HR Extended Release Oral Tablet

RxCUI
862027
RxNorm name
Intuniv 4 MG 24 HR Extended Release Oral Tablet
Display name
Intuniv 4 MG 24 HR Extended Release Oral Tablet
Full name
Intuniv 4 MG 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IntunivGUANFACINETakeda Pharmaceuticals America, Inc.b972af81-3a37-40be-9fe1-3ddf598525282025-06-23Warnings, Adverse reactionsExact identifier
rxcui: 862027

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b972af81-3a37-40be-9fe1-3ddf59852528intuniv 4 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR guanfacine 4 MG Extended Release Oral Tablet [Intuniv] [SBD] · Intuniv 4 MG (as guanfacine hydrochloride 4.6 MG) 24 HR Extended Release Oral Tablet [SY] · Intuniv 4 MG 24 HR Extended Release Oral Tablet [SY]444These highlights do not include all the information needed to use INTUNIV ® safely and effectively. See full prescribing information for INTUNIV. INTUNIV ® (guanfacine) extended-release tablets, for oral use Initial U.S. Approval: 198620250623